ACI Joins Coalition Letter in Support of Biosimilar Competition BySteve Pociask July 1, 2021July 1, 2021
The Maine Wire: Congress Should Preserve Public Quality Standards for Biologic Drugs ByLiam Sigaud August 28, 2019
Coalition Letter Calling on the Senate Not to End the Current Development of Quality Standards for Biologics Byeditor July 23, 2019September 18, 2019
Regulatory Uncertainty and Industry Practices Force Consumers to Overpay on Biologics ByAlan Daley February 19, 2019
Forbes: Biosimilar Competition Will Lower Consumer Prices BySteve Pociask November 20, 2015February 14, 2019
